Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer center
RT appears safe for patients with CCA who receive chemoimmunotherapy, with promising survival outcomes. Immune kinetics and other standard clinicopathological features may identify important prognostic differences amongst patients and help guide management decisions.
Authors
- Michael Kevin Rooney (ORCID: https://orcid.org/0000-0002-2860-4653)
- Ethan B. Ludmir (ORCID: https://orcid.org/0000-0002-5472-5344)
- Eugene J. Koay (ORCID: https://orcid.org/0000-0001-7675-3461)
- Sonal S. Noticewala (ORCID: https://orcid.org/0000-0002-3153-0317)
- Milind M. Javle (ORCID: https://orcid.org/0000-0001-9158-0941)
- Grace L. Smith (ORCID: https://orcid.org/0000-0002-3171-2911)
- Ian Hu (ORCID: https://orcid.org/0009-0009-8605-0036)
- Lianchun Xiao (ORCID: https://orcid.org/0000-0003-0972-2766)
- Albert C. Koong (ORCID: https://orcid.org/0000-0001-9824-1643)
- Aqua Asif (ORCID: https://orcid.org/0000-0003-3233-7428)
- Vincent Bernard (ORCID: https://orcid.org/0000-0003-1555-608X)
- Prajnan Das (ORCID: https://orcid.org/0000-0002-3845-0707)
- Sunyoung Lee (ORCID: https://orcid.org/0000-0002-6893-3136)
- Enoch Chang (ORCID: https://orcid.org/0000-0002-2879-5445)
- Felicity K. Namayanja
- Emma B Holiday
- Kimana Quentin (ORCID: https://orcid.org/0009-0006-8831-7775)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jgo-2025-300
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00